FDA approves Biogen's $56,000 drug for Alzheimer's

FDA approves Biogen's $56,000 drug for Alzheimer's

By Anna Domanska - Jun 09, 2021

The Food and Drug Administration of the US approved on Monday Biogen Inc’s Aducanumab to treat Alzheimer’s disease amidst the controversy of its efficacy. Biogen has pr

Read More